Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04749134
Other study ID # CFTSp170
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 1, 2021
Est. completion date January 31, 2026

Study information

Verified date May 2023
Source The Christie NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Non-patient volunteers will be scanned on the MR-Linac and MRSIM to facilitate the development, optimisation and validation of MRI protocols at The Christie NHS Foundation Trust.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date January 31, 2026
Est. primary completion date January 31, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - Willing and able to provide written consent - Volunteers must undergo and satisfy MRI safety screening - Volunteers must be = 16 years of age - Participants must agree to registration as a non-patient in CWP (the Trust's Electronic Health Record - EHR- system) and have their MRIs read and reported for incidental findings by a clinical radiologist Exclusion Criteria: - Any contraindications to MRI identified after MRI safety screening including completion of an MRI Safety Screening Form - Unable to tolerate MRI scan - Known Pregnancy - Known or suspected pathology in body region to be scanned - Member of study team

Study Design


Related Conditions & MeSH terms

  • Focus of the Study is MRI Sequence Development

Locations

Country Name City State
United Kingdom The Christie NHS FT Manchester

Sponsors (1)

Lead Sponsor Collaborator
The Christie NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Developed and optimised of MRI scanning sequences for use in clinical radiotherapy practice in MR guided radiotherapy on-going development of MRI protocols to be released for clinical use Through study completion - up to 5 years